NCT03413436View on ClinicalTrials.gov

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

PHASE4CompletedINTERVENTIONAL
Enrollment

733

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

February 21, 2018

Study Completion Date

February 21, 2018

Conditions
Esophageal Cancer
Interventions
DRUG

Lobaplatin

at least one cycle adjuvant chemotherapy after esophagectomy

DRUG

Cisplatin

at least one cycle adjuvant chemotherapy after esophagectomy

Trial Locations (1)

450008

Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university, Zhengzhou

All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV

NCT03413436 - Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma | Biotech Hunter | Biotech Hunter